Teclison Ltd.   Report issue

For profit Phase 2
Founded: Richmond VA United States (2015)

Organization Overview

First Clinical Trial
2015
NCT02174549
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Teclison Limited | Teclison Ltd.